Geometry.Net - Health_Conditions: Hyperhomocysteinemia


Home - Health_Conditions - Hyperhomocysteinemia

e99.com Bookstore

Images

Newsgroups

61-80 of 82 Back | 1 | 2 | 3 | 4 | 5 | Next 20

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Hyperhomocysteinemia: more detail

Hyperhomocysteinemia: Webster's Timeline History, 1992 - 2007 by Icon Group International, 2009-02-20
Hyperhomocysteinemia as a result of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism causes an increased risk of cerebrovascular disease: ... An article from: Original Internist by Robert A., Jr. Duca, 2010-09-01
Hyperhomocysteinemia in end stage renal disease: is treatment necessary? (Continuing Education).: An article from: Nephrology Nursing Journal by Jennifer Snavely, 2002-04-01

lists with details

Project: Hyperhomocysteinemia And Kidney Disease (NIWI)
from Project Hyperhomocystei . entire NIWI site (en), Help. Project hyperhomocysteinemia and kidney disease. switch to nl. mutation.
http://www.niwi.knaw.nl/en/oi/nod/onderzoek/OND1259262/toon

Extractions: Login NIWI (en) Research Information NOD - Dutch Research Database ... Powered by from "Project: Hyperhomocystei..." entire NIWI site (en) Titel Hyperhomocysteïnemie en nierziekte Abstract Objectives: Hyperhomocysteinaemia is universal in patients with chronic renal failure and may contribute to the high risk of atherothrombotic disease in these patients. We set out to investigate causes and consequences of hyperhomocysteinaemia in chronic renal failure patients.
ROLE OF HYPERHOMOCYSTEINEMIA IN THE DEVELOPMENT OF ATHEROSCLEROSIS
153, Return to Table of Contents. ROLE OF hyperhomocysteinemia IN THE DEVELOPMENT OF ATHEROSCLEROSIS*. J Zhou, GH Werstuck, L Watson
http://www.ccs.ca/society/congress2002/abstracts/abs/a153.htm
RESISTANCE ARTERY MECHANICS IN MICE WITH HYPERHOMOCYSTEINEMIA: EFFECTS OF ANGIOT
245, Return to Table of Contents. RESISTANCE ARTERY MECHANICS IN MICE WITH hyperhomocysteinemia EFFECTS OF ANGIOTENSIN II. Mario Fritsch
http://www.ccs.ca/society/congress2002/abstracts/abs/a245.htm

Extractions: Hyperhomocysteinemia (H-Hcy) may be an independent risk factor for atherosclerotic vascular disease. The purpose of this study was to evaluate whether hyperhomocysteinemia may induce direct vascular changes. Wild-type (+/+) and heterozygous (+/-) methylenetetrahydrofolate reductase (Mthfr) knockout mice, a model of mild H-Hcy, were divided in four groups for a 2-week treatment: wild-type with vehicle infusion (+/+ sham), wild-type with angiotensin (Ang) II infusion (400 ng/Kg/min s.c.), Mthfr +/- sham and Mthfr +/- with Ang II. Second-order branches of mesenteric arteries (lumen diameter 0.05). In Mthfr +/- mice Ang II induced hypertrophic remodeling with increased M/L ratio (7.2 ± 0.2 vs 6.3 ± 0.3 %, p
Blackwell Synergy - Cookie Absent
CASE REPORT. Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis. hyperhomocysteinemia.
http://www.blackwell-synergy.com/links/doi/10.1111/j.1365-2257.2004.00585.x/full

Extractions: Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.
Blackwell Synergy - Cookie Absent
hyperhomocysteinemia in pediatric and young adult renal transplant recipients. hyperhomocysteinemia in renal transplant recipients with cyclosporine.
http://www.blackwell-synergy.com/links/doi/10.1046/j.1399-3046.2003.00144.x/enha

Extractions: Home An Error Occurred Setting Your User Cookie A cookie is a small amount of information that a web site copies onto your hard drive. Synergy uses cookies to improve performance by remembering that you are logged in when you go from page to page. If the cookie cannot be set correctly, then Synergy cannot determine whether you are logged in and a new session will be created for each page you visit. This slows the system down. Therefore, you must accept the Synergy cookie to use the system. What Gets Stored in a Cookie? Synergy only stores a session ID in the cookie, no other information is captured. In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a web site to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it. Please read our for more information about data collected on this site.
WebMD Health
Re hyperhomocysteinemia by CardiostarUSA1, on 4/30/2004 101440 PM Hi Meanwhile There are even bigger words used in the medical community.
http://boards.webmd.com/message.asp?message_id=6680009
Nephrology Nursing Journal : Hyperhomocysteinemia In End Stage Renal Disease: Is
Nephrology Nursing Journal hyperhomocysteinemia in end stage renal disease is treatment necessary? (Continuing Education). @ HighBeam Research.
http://static.highbeam.com/n/nephrologynursingjournal/april012002/hyperhomocyste
Diabetes Care : Hyperhomocysteinemia In Type 2 In Type 2 Diabetes.(Brief Article
Diabetes Care hyperhomocysteinemia in Type 2 in Type 2 Diabetes.(Brief Article) @ HighBeam Research. Read Diabetes Care hyperhomocysteinemia
http://static.highbeam.com/d/diabetescare/december012000/hyperhomocysteinemiaint

Extractions: Tour Become a Member ... Customer Support Question / Keyword(s): Advanced Search Start D Diabetes Care December 01, 2000 ... Hyperhomocysteinemia in Type 2 in Type 2 Diabetes.(Brief Article) Diabetes Care; December 01, 2000; BUYSSCHAERT, MARTIN DRAMAIS, ANNE-SOPHIE WALLEMACQ, PIERRE F. HERMANS, MICHEL P.
Preventive Health Care, 2000 Update Screening And Management Of
Preventive health care, 2000 update screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events.
http://collection.nlc-bnc.ca/100/201/300/cdn_medical_association/cmaj/vol-163/is
Ingenta: Article Summary -- Hyperhomocysteinemia Activates NF-kappaB And Inducib
hyperhomocysteinemia activates NF B and inducible nitric oxide synthase in the kidney Kidney International April 2004, vol. 65, no. 4, pp.
http://www.ingenta.com/isis/searching/ExpandTOC/ingenta?issue=pubinfobike://bsc/
Ingenta: Article Summary -- Moderate Hyperhomocysteinemia And Immune Activation
Moderate hyperhomocysteinemia and Immune Activation Current Pharmaceutical Biotechnology February 2004, vol. 5, no. 1, pp. 107118
http://www.ingenta.com/isis/searching/ExpandTOC/ingenta?issue=pubinfobike://ben/
ANNA - Continuing Education Articles
hyperhomocysteinemia in End Stage Renal Disease Is Treatment Necessary? Objectives 1. Explain homocystein metabolism and list causes of hyperhomocysteinemia.
http://www.hdcn.com/anna_ce/292/292.htm
Seminar Details
Professor of Biological Chemistry and Research Professor, Life Sciences Institute, University of Michigan Riboflavin and hyperhomocysteinemia Monday, May 17
http://www.genomics.upenn.edu/events/seminars/files/511.html
News - An Anti-Atherosclerosis Aid For Adults With Hyperhomocysteinemia?
my personal edition vascular disorders news EMail this DGReview to a colleague DGReview An Anti-Atherosclerosis Aid For Adults With hyperhomocysteinemia?
http://www.docguide.com/news/content.nsf/news/8525697700573E1885256BBB0055AE4D

Extractions: Unregistered User Click here if this is not your Personal Edition Contact Us Free E-Mail Updates Journals ... Register a colleague Select a Channel Acne Addictions AIDS and HIV Allergy Other Alzheimer's Anaemia Anaesthesiology Other Angina Pectoris/MI Anxiety Arthritis Other Asthma Back Pain Bacterial Infections Bladder Cancer Bone Marrow and PBSC Transplantation Breast Cancer Burns Cardiology Other Cataract Cervical Cancer Cholesterol/Lipid Disorders Cirrhosis Clinical Pharmacology Colorectal Cancer Congestive Heart Failure Contraception Cornea COPD Cystic Fibrosis Dental and Oral Disorders Depression Dermatitis Dermatology Other Diabetes Diagnostic Radiology Dialysis Eating Disorders Elbow Emergency Medicine Endocrinology Other Epilepsy Erectile Dysfunction Fibromyalgia Gastro Other Genetics Genitourinary Other Geriatrics GERD/Gastritis GIST Glaucoma H. Pylori/Ulcer Haematology Other Hair Loss Head and Neck Cancer Hepa/Biliary Other Hepatitis C Hepatitis Other Herpes Hip HRT Hypertension IBD Immunology Infectious Other Infertility Intensive Care Interventional Cardiology Interventional Radiology Irritable Bowel Syndrome Knee Leukemias Liver Cancer Lung Cancer Lupus Lymphomas Melanoma Menopause Migraine Multiple Sclerosis Mycoses Nephrology Other Neurologic Other Nuclear Medicine Nutritional / Metabolic Other Ob/Gyn Other Obesity Oncology Other Ophth. Other
Entrez PubMed
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid
http://arthritis-research.com/pubmed/9517760

Extractions: Summary Brief Abstract Citation ASN.1 MEDLINE XML UI List LinkOut Related Articles Cited in Books CancerChrom Links Domain Links 3D Domain Links GEO DataSet Links Gene Links Genome Links GEO Links HomoloGene Links Nucleotide Links OMIM Links PMC Links Cited in PMC PopSet Links Protein Links SNP Links Structure Links UniSTS Links Show: Sort Author Journal Pub Date Text File Clipboard E-mail Order
PCCU Volume 17, Lesson 3
hyperhomocysteinemia. The stenosis. hyperhomocysteinemia has also been shown to be a risk factor for venous thromboembolic disease.
http://www.chestnet.org/education/online/pccu/vol17/lessons3_4/lesson03/p10.php

Extractions: www ChestNet Foundation Journal home education online pccu Quick Navigation Home Education Meeting NetWorks About CME Information Editorial Board Volume 18 Volume 17 ... Volume 12 By Julie Hambleton, MD Print This TOC Previous Next Hyperhomocysteinemia The early descriptions of patients with hyperhomocysteinemia involved homozygous mutations in genes encoding for enzymes of homocysteine metabolism resulting in a severe multisystem disease with neurologic and vascular manifestations. Severe elevations in plasma homocysteine are also associated with homozygous defects of the methylenetetrahydrofolate reductase ( MTHFR ) gene or of various enzymes that participate in the vitamin B cycle. However, these mutations are uncommon. The more common causes of hyperhomocysteinemia are subtle in presentation and may be caused by less severe defects in genes encoding for enzymes or from inadequate status of those vitamins that are involved in homocysteine metabolism. Inadequate folate, vitamin B , or pyridoxine may result in a substantial increase in plasma homocysteine concentrations. More recently, a thermolabile polymorphism of the
Www.hon.ch/cgi-bin/HONselect?browse+C18.452.648.066.480
hyperhomocysteinemiahyperhomocysteinemia. Slide 31 of 33.
http://www.hon.ch/cgi-bin/HONselect?browse C18.452.648.066.480
HUM-MOLGEN Events: 3rd Conference On Hyperhomocysteinemia, Saarbruecken/Germany
3rd Conference on hyperhomocysteinemia, Saarbruecken/Germany, August 21, 2002, Medical Research (others). Central Laboratory Saarland
http://www.hum-molgen.de/meetings/meetings/1875.html
HNRCA : Hyperhomocysteinemia Associated With Poor Recall In An Nationally Repres
Citation, Morris MS, Jacques PF, Rosenberg IH, Selhub J. hyperhomocysteinemia associated with poor recall in the third National Health and Nutrition Examination
http://hnrcwww.hnrc.tufts.edu/publications/detail.php?id=115256
HYPERHOMOCYSTEINEMIA IS A RISK FACTOR FOR STROKE: REPORT OF 20 CASES
hyperhomocysteinemia IS A RISK FACTOR FOR STROKE REPORT OF 20 CASES. MR Carriero, L. Chiapparini, E. Ciusani, A. Attanasio, C. Ariano
http://www.kenes.com/stroke5/Abstracts/34.htm

Extractions: G.B Boncoraglio, G. Bussone, E.A Parati Istituto Nazionale Neurologico Carlo Besta, Milano, Italy Purpose: To describe cerebrovascular events in 20 patients affected by hyperhomocysteinemia. Methods: We evaluated clinical and neuroradiological findings (CT, MR, duplex US or DSA) in 20 patients (7 females, 13 males, 27 to 55 yrs). In all patients biochemical tests, serum folate, cobalamin level, homocysteine level (MEIA), protein C, protein S, antiphospholipid antibodies, FV-Leiden and protrombin mutation (20120A) were performed. Results: Conclusions: Mild hyperhomocysteinemia may be an additional thrombogenic risk factor for stroke. The inclusion of homocysteine determination is useful in stroke patients, besides high levels may be corrected with vitamins therapy.`

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

61-80 of 82 Back | 1 | 2 | 3 | 4 | 5 | Next 20